CRP at early follicular phase of menstrual cycle can cause misinterpretation for cardiovascular risk assessment

Interventional Medicine and Applied Science

Volumn 7, Issue 4, 2015, Pages 143-146

  Gursoy, Asli Yarci ^a   Caglar, Gamze Sinem ^a   Kiseli, Mine ^a   Pabuccu, Emre ^a   Candar, Tuba ^a   Demirtas, Selda ^a  

^a UFUK UNIVERSITY   (Turkey)

Author keywords

CRP; Early follicular phase; Menstruation

Indexed keywords

C REACTIVE PROTEIN; ESTRADIOL; FOLLITROPIN; PROGESTERONE;

ADULT; ARTICLE; BLOOD COLLECTION TUBE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; CARDIOVASCULAR RISK ASSESSMENT; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; ERYTHROCYTE SEDIMENTATION RATE; ESTRADIOL BLOOD LEVEL; EVALUATION AND FOLLOW UP; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HUMAN; IMMUNOASSAY ANALYZER; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; VENOUS BLOOD;

EID: 84953273215     PISSN: 20611617     EISSN: 20615094     Source Type: Journal    
DOI: 10.1556/1646.7.2015.4.2     Document Type: Article

References (25)

1. Pieri G, Agarwal B, Burroughs AK: C-reactive protein and bacterial infection in cirrhosis. Ann Gastroenterol 27(2), 113-120 (2014)
2. Woloshin S, Schwartz LM: Distribution of C-reactive protein values in the United States. N Engl J Med 352(15), 1611-1613 (2005)
3. Wener MH, Daum PR, McQuillan GM: The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 27(10), 2351-2359 (2000)
4. Casas JP, Shah T, Hingorani A.D., Danesh J., Pepys MB: C-reactive protein and coronary heart disease: A critical review. J Intern Med 264(4), 295-314 (2008)
5. Kushner I, Samols D, Magrey MA: Unifying biologic explanation for "high-sensitivity" C-reactive protein and "low-grade" inflammation. Arthritis Care Res (Hoboken) 62(4), 442-446 (2010)
6. Pietri P, Vlachopoulos C, Tousoulis D: Inflammation and arterial hypertension: From pathophysiological links to risk prediction. Curr Med Chem [Epub ahead of print] (2015)
7. Pearson TA, Mensah GA, Alexander R.W., Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F, Centers for Disease Control and Prevention, American Heart Association: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3), 499-511 (2003)
8. Brito V, Alcaraz A, Augustovski F., Pichón-Riviere A, García-Martí S, Bardach A, Ciapponi A, Lopez A, Comandé D, Grupo de Evaluación de Tecnologías Sanitarias: High sensitivity C protein as an independent risk factor in people with and without history of cardiovascular disease. Arch Cardiol Mex 85(2), 124-135 (2015)
9. Stauffer BL, Hoetzer GL, Smith D.T., DeSouza CA: Plasma C reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy. J Appl Physiol 96, 143-148 (2004)
10. De Maat M.P., Kluft C: Determinants of C-reactive protein concentration in blood. Ital Heart J 2, 189-195 (2001)
11. Suk HJ, Ridker PM, Cook N.R., Zee RY: Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178, 139-145 (2005)
12. Williams MJ, Williams SM, Milne B.J., Hancox RJ, Poulton R: Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Int J Obes Relat Metab Disord 28(8), 998-1003 (2004)
13. Ridker PM: Cardiology patient page. C-reactive protein: Simple test to help predict risk of heart attack and stroke. Circulation 108(12), e81-85 (2003)
14. Gaskins AJ, Wilchesky M, Mumford S.L., Whitcomb BW, Browne RW, Wactawski-Wende J, Perkins NJ, Schisterman EF: Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: The BioCycle Study. Am J Epidemiol 175(5), 423-431 (2012)
15. Wander K, Brindle E, O'Connor KA: C-reactive protein across the menstrual cycle. Am J Phys Anthropol 136(2), 138-146 (2008)
16. Wunder DM, Yared M, Bersinger N.A., Widmer D., Kretschmer R, Birkhäuser MH: Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age women. Eur J Endocrinol 155(1), 137-142 (2006)
17. Blum CA, Müller B, Huber P., Kraenzlin M, Schindler C, De Geyter C, Keller U, Puder JJ: Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women. J Clin Endocrinol Metab 90(6), 3230-3235 (2005)
18. Capobianco G, de Muro P, Cherchi GM, Formato M, Lepedda A.J., Cigliano A., Zinellu E, Dessole F, Gordini L., Dessole S: Plasma levels of C-reactive protein, leptin, and glycosaminoglycans during spontaneous menstrual cycle: Differences between ovulatory and anovulatory cycles. Arch Gynecol Obstet 282(2), 207-213 (2010)
19. Jilma B, Dirnberger E, Löscher I, Rumplmayr A., Hildebrandt J, Eichler HG, Kapiotis S, Wagner OF: Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein. J Lab Clin Med 130(1), 69-75 (1997)
20. Puder JJ, Blum CA, Mueller B, De Geyter Ch, Dye L, Keller U: Menstrual cycle symptoms are associated with changes in lowgrade inflammation. Eur J Clin Invest 36(1), 58-64 (2006)
21. Schueller PO, Feuring M, Sharkova Y., Grimm W, Christ M: Effects of synthetic progestagens on autonomic tone, neurohormones and C-reactive protein levels in young healthy females in reproductive age. Int J Cardiol 111(1), 42-48 (2006)
22. Bell HK, Bloomer RJ: Impact of serum estradiol on postprandial lipemia, oxidative stress and inflammation across a single menstrual cycle. Gend Med 7(2), 166-178 (2010)
23. Rota S, Alata E, Yildirim B: C-reactive protein and the menstrual cycle. Türkiye Klinikleri J Med Sci 25(1), 6-9 (2005)
24. Gursoy AY, Kiseli M, Ozdemir S., Seker R, Caglar GS: Menstrual cycle variability of CA 72-4 in healthy women. Clin Biochem 48(1-2), 70-72 (2014)
25. Faas M, Bouman A, Moesa H., Heineman MJ, de Leij L, Schuiling G: The immune response during the luteal phase of the ovarian cycle: A Th2-type response? Fertil Steril 74(5), 1008-1013 (2000)